CClinicalTrials.gg
CompletedNCT05685251STAC-MyHEARTpUpdated Aug 28, 2025

Staying Healthy After Childbirth: My Hypertension Education and Reaching Target Program for Postpartum

An interventional study of Health Coaching and Home Blood Pressure Monitoring in Hypertension, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-28.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

A study of Staying Healthy After Childbirth (STAC) and My Hypertension Education And Reaching Target (MyHEART) for postpartum (p) patients to determine if health coaching can increase 12-month postpartum care attendance, hypertension control and hypertension self-management behavior compared to usual clinical care in patients with chronic hypertension or persistent pregnancy associated hypertension - postpartum. 140 participants will be enrolled and can expect to be on study for 12 months.

Read the detailed description

To address the critical need for hypertension (HTN) control in young adults, the investigators developed the MyHEART (My Hypertension Education And Reaching Target) program, a multi-component patient-centered, theoretically-based intervention designed to increase self-management using evidence-based health behavior approaches to lower BP among young adults with uncontrolled HTN.

A nonrandomized, single-center pilot study of MyHEART was conducted, which established feasibility, satisfaction, and informed the design of this trial. A large, multi-site randomized-controlled trial to evaluate the effect of MyHEART (home blood pressure monitor distribution and heath coaching) on clinical outcomes, the change in systolic and diastolic blood pressure (primary) and HTN control (secondary) after 6 and 12 months, compared to usual clinical care was completed. Additionally, lifestyle changes and HTN self-management behavior were evaluated.

Incorporating components of the MyHEART intervention with routine clinical care can support HTN behavioral changes in young adults with uncontrolled HTN to support BP lowering in this population. The investigators are in a unique position to partner with the Perinatal Clinic and the current STAC program, to improve health outcomes for women with HTN during pregnancy through health coaching and BP surveillance through 12-months postpartum.

Specific Aims:

  • Aim 1: To improve postpartum attendance for 12-month hypertension follow-up care among Staying Healthy After Childbirth patients who have chronic hypertension or persistent hypertension at 6-weeks postpartum.

    • Hypothesis: Postpartum follow up care will improve in the intervention compared to usual care.
  • Aim 2: To improve blood pressure control at 12-months in postpartum patients with chronic hypertension or a hypertension disorder of pregnancy with persistent HTN at 6-weeks postpartum.

    • Hypothesis: Blood pressure control will improve in the intervention (health coaching) arm compared to the usual care arm, via chart review from the 12-month postpartum appointment, and on ambulatory blood pressure monitoring compared to usual care.
  • Aim 3: To increase lifestyle modification behaviors and health outcomes relating to nutrition and physical activity and cardiovascular disease (CVD) prevention in postpartum patients with chronic hypertension or a hypertension disorder of pregnancy with persistent HTN at 6-weeks postpartum.

    • Hypothesis: Health outcomes including, weight, lipid profile, A1c and microalbumin creatine ratio will improve in the intervention compared to usual care arm, via study surveys and upon chart review from the 12-month postpartum appointment.

Aim 1-3: A total of 140 participants will be enrolled and randomly assigned to the intervention and usual care arms.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • postpartum
  • chronic hypertension
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 140 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Willing and capable of giving written informed consent
  • Willing to comply with all study procedures and be available for the duration of the study
  • Genetically female
  • Patients who complete the 6-week program, had a hypertension disorder of pregnancy who have persistent hypertension (systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg) and/or are still on antihypertensive medication and those with chronic hypertension (CHTN) will be eligible to participate.
  • Medically homed at UW Health or UPH

Exclusion criteria

Exclusion Criteria:

  • Inability to participate in health coaching (i.e., no reliable phone contact or Wi-Fi
  • History of medically determined Congestive Heart Failure
  • Unable to provide informed consent (i.e., activated healthcare power of attorney)
  • Unable or unwilling to travel to local clinic for research visits
  • Currently residing in a skilled nursing facility
  • Diagnosed with sickle cell anemia or cystic fibrosis
  • Diagnosed with stroke, myocardial infarction, and/or coronary artery revascularization in the past 2 years
  • Syncope while exercising or doing strenuous activity within past 12 months
  • Currently prescribed warfarin, novel oral anticoagulant, or insulin
  • Planned organ transplant or prior transplant in the past 5 years
  • Chemotherapy or radiation therapy within 6 the past months
  • Severely impaired hearing, vision, or speech, as determined by study staff responsible for enrollment
  • Current participation or planning to participate in another clinical trial in the next 12 months that involves hypertension management/control
  • Pregnant or planning to become pregnant in the next 12 months
  • Planning to leave the geographic area in the next 12 months
  • Health condition that will limit both increasing physical activity and changing diet
  • Illegal drug use (other than marijuana) in the past 30 days
  • Unable to read or communicate in English
  • Currently on dialysis or seeing a Nephrologist
  • Unaware or denies history of high blood pressure or hypertension
  • Between-arm blood pressure difference >20 mmHg
  • Inability to comply with or complete the protocol or other reasons at the discretion of the principal and site investigators
  • Prisoners
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
140 participants (actual)

Study arms

  • Experimental
    Health Coaching

    Other: Health Coaching · Other: Home Blood Pressure Monitoring

  • No intervention
    Standard of Care

Interventions

  • OtherHealth Coaching

    Participants will receive a health coach telehealth/video visit or phone call every 2 weeks for 4 months, for a total of 8 calls. After these initial 8 calls, at approximately 6 months postpartum, the health coach will schedule maintenance calls 1 per month until approximately 12 months postpartum, for a total of 6 additional calls.

  • OtherHome Blood Pressure Monitoring

    Participants will be provided an A\&D UA-651 (BT) home blood pressure monitor with an appropriate cuff size, they will be asked to take their blood pressure at least three days a week, 2 measurements each time

06

What researchers measure

Primary outcomes

  1. Number of Participants Who Attend 12 month Postpartum Care Visit

    Time frame: up to 12 months

Secondary outcomes

  1. Difference in Self-Reported and Electronic Medical Record (EMR) documented BP at 6 months postpartum

    Time frame: up to 6 months

  2. Lipid Profile at 12 months postpartum

    Time frame: 12 months

  3. Hemoglobin A1c at 12 months postpartum

    Time frame: 12 months

  4. Microalbumin Creatine Ratio at 12 months postpartum

    Time frame: 12 months

  5. Percentage of participants that achieve hypertension control at 12 months postpartum

    Hypertension control will be defined using ambulatory blood pressures as the gold standard (less than 130/80 mmHg); otherwise a clinic blood pressure of less than 140/90 mmHg will be used.

    Time frame: 12 months

  6. Hypertension Control: Number of Participants who initiate, titrate, or cease BP medications

    Time frame: up to 12 months

  7. Hypertension Control: Summary of Antihypertensive Type

    Time frame: up to 12 months

  8. Dietary Changes: Change in Sodium intake (milligrams/day) as assessed by the Automated Self-Administered 24-hour Dietary Assessment

    Change in hypertension self-management behavior at 6 and 12 months compared to usual care will in part be assessed by dietary changes documented on an automated self-administered 24 hour dietary assessment.

    Time frame: 6 and 12 months

  9. Change in physical activity as measured by the Godin Physical Activity Questionnaire

    Change in hypertension self-management behavior at 6 and 12 months compared to usual care will in part be assessed by change in physical activity as measured by the Godin Physical Activity Questionnaire at 6 and 12 months. The Godin Physical Activity Questionnaire measures a person's strenuous, moderate, and light physical activity in a week. A score of less than 14 is interpreted as insufficiently active or sedentary, a score between 14 and 23 is interpreted to be moderately active, and a score of 24 and higher is interpreted to be active.

    Time frame: 6 and 12 months

  10. Change in Home Blood Pressure Monitoring Frequency

    Change in hypertension self-management behavior at 6 and 12 months compared to usual care will in part be assessed by measuring the frequency of home blood pressure monitoring.

    Time frame: 6 and 12 months

  11. Change in Weight (kg)

    Change in hypertension self-management behavior at 6 and 12 months compared to usual care will in part be assessed by documenting participant weight at 6 and 12 months.

    Time frame: 6 and 12 months

  12. Change in Body Mass Index (BMI)

    Change in hypertension self-management behavior at 6 and 12 months compared to usual care will in part be assessed by documenting participant BMI at 6 and 12 months.

    Time frame: 6 and 12 months

07

Study locations

1 site
  • UW Hospital and Clinics
    Madison, Wisconsin 53792, United States
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05685251
Lead sponsor
University of Wisconsin, Madison
Collaborators
Meriter Foundation
Responsible party
Sponsor
First posted
Jan 17, 2023
Start date
Feb 22, 2023
Primary completion
Apr 10, 2025
Completion
Apr 10, 2025
Last update
Aug 28, 2025

Study contacts

Kara K Hoppe, DO
principal investigator · University of Wisconsin, Madison

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion